Michael Vanyukov is Professor, Depts. of Pharmaceutical Sciences, Psychiatry, and Human Genetics at the University of Pittsburgh School of Pharmacy, School of Medicine and Graduate School of Public Health, respectively. He received a MS in Genetics from the M.V. Lomonosov Moscow State University, Moscow, USSR, and Ph.D. in Genetics from the USSR Academy of Medical Sciences Institute of Medical Genetics. In the Soviet Union, he conducted research in pharmacogenetics and in the mechanisms of the family transmission of alcoholism risk. In December 1990, he immigrated in the USA, and in 1991 he joined the University of Pittsburgh and the faculty of the Center for Education and Drug Abuse Research (CEDAR), a NIDA-funded longitudinal family/high-risk study of substance abuse. Together with other colleagues from CEDAR, in January 2000 he moved from the School of Medicine to the School of Pharmacy, Department of Pharmaceutical Sciences. He is currently Scientific Director of CEDAR.
Dr. Vanyukov's research program has focused on the mechanisms of the development of addiction and associated traits. His research has been directed at the role of neurobiology-related genes in the risk for addiction. This information is provided by Dr. Vanyukov's NIH-funded projects that comprise the genetic program of CEDAR.